ACADIA Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences
May 05 2020 - 04:05PM
Business Wire
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will present at the following two investor conferences:
- 2020 BofA Securities Health Care Conference on Tuesday, May 12,
2020, at 11:00 a.m. Eastern Time.
- 2020 RBC Capital Markets Global Healthcare Conference on
Tuesday, May 19, 2020, at 1:55 p.m. Eastern Time.
These conferences will both be held virtually. Live webcasts of
ACADIA’s presentations will be accessible on the company’s website,
www.acadia-pharm.com, under the investors section and an archived
recording will be available on the website for approximately one
month following each presentation.
About ACADIA Pharmaceuticals
ACADIA is a biopharmaceutical company focused on the development
and commercialization of innovative medicines to address unmet
medical needs in central nervous system disorders. ACADIA has
developed and commercialized the first and only medicine approved
for the treatment of hallucinations and delusions associated with
Parkinson’s disease psychosis. ACADIA also has ongoing clinical
development efforts in additional areas with significant unmet
need, including dementia-related psychosis, major depressive
disorder, the negative symptoms of schizophrenia, and Rett
syndrome. This press release and further information about ACADIA
can be found at: www.acadia-pharm.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200505005964/en/
Media Contact: ACADIA Pharmaceuticals Inc. Stephanie Fagan (858)
212-0534 media@acadia-pharm.com
Investor Contact: ACADIA Pharmaceuticals Inc. Mark Johnson, CFA
(858) 261-2771 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2023 to Mar 2024